WELCOME TO ONCOSCIENCE

About Us

Oncoscience GmbH develops therapeutic options for rare diseases in oncology.

CLICK HERE FOR MORE INFO


ONCOLOGY

Oncology and Orphan Drugs

Cancer is one of the leading causes of death worldwide and e.g. in Germany the second leading cause of death after cardiovascular diseases.

CLICK HERE FOR MORE INFO

NEWS

Nimotuzumab on ASCO 2022

Oncoscience | June 7th, 2022

  Once again, Nimotuzumab’s efficacy and safety in several cancer types were discussed and analyzed thorou...

Webinar – The Role of Nimotuzumab in the Treatment of Head and Neck and Nasopharyngeal Cancer

Oncoscience | May 28th, 2022

  This webinar was conducted on May 28th, 2022 discussing the role of Nimotuzumab in the treatment of locall...

Specific Pharma A/S and Oncoscience GmbH launch a Named Patient Program for the treatment of cancer with nimotuzumab.

Oncoscience | November 6th, 2020

Specific Pharma announced today that it has entered into a supply and distribution collaboration with German based Onc...